Search Page

1

Cite

Share

Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study.

Stenzl A, Dunshee C, De Giorgi U, Alekseev B, Iguchi T, Szmulewitz RZ, Flaig TW, Tombal B, Morlock R, Ivanescu C, Ramaswamy K, Saad F, Armstrong AJ. Stenzl A, et al. Among authors: morlock r. Eur Urol. 2020 Oct;78(4):603-614. doi: 10.1016/j.eururo.2020.03.019. Epub 2020 Apr 23. Eur Urol. 2020. PMID: 32336645 Free article.

Cite

Share

2

Cite

Share

Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.

Tombal B, Saad F, Penson D, Hussain M, Sternberg CN, Morlock R, Ramaswamy K, Ivanescu C, Attard G. Tombal B, et al. Among authors: morlock r. Lancet Oncol. 2019 Apr;20(4):556-569. doi: 10.1016/S1470-2045(18)30898-2. Epub 2019 Feb 12. Lancet Oncol. 2019. PMID: 30770294 Clinical Trial.

Cite

Share

3

Cite

Share

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder.

Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Matza LS, et al. Among authors: morlock r. Int J Methods Psychiatr Res. 2010 Dec;19(4):223-32. doi: 10.1002/mpr.323. Epub 2010 Aug 18. Int J Methods Psychiatr Res. 2010. PMID: 20718076 Free PMC article.

Cite

Share

4

Cite

Share

Incident gout and chronic Kidney Disease: healthcare utilization and survival.

Jaffe DH, Klein AB, Benis A, Flores NM, Gabay H, Morlock R, Teltsch DY, Chapnick J, Molad Y, Giveon SM, Feldman B, Leventer-Roberts M. Jaffe DH, et al. Among authors: morlock r. BMC Rheumatol. 2019 Mar 19;3:11. doi: 10.1186/s41927-019-0060-0. eCollection 2019. BMC Rheumatol. 2019. PMID: 30937425 Free PMC article.

Cite

Share

5

Cite

Share

Targeted literature review of the global burden of gastric cancer.

Casamayor M, Morlock R, Maeda H, Ajani J. Casamayor M, et al. Among authors: morlock r. Ecancermedicalscience. 2018 Nov 26;12:883. doi: 10.3332/ecancer.2018.883. eCollection 2018. Ecancermedicalscience. 2018. PMID: 30679950 Free PMC article. Review.

Cite

Share

6

Cite

Share

Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews.

Holmstrom S, Naidoo S, Turnbull J, Hawryluk E, Paty J, Morlock R. Holmstrom S, et al. Among authors: morlock r. Patient. 2019 Feb;12(1):57-67. doi: 10.1007/s40271-018-0349-x. Patient. 2019. PMID: 30519830

Cite

Share

7

Cite

Share

Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.

Stack AG, Johnson ME, Blak B, Klein A, Carpenter L, Morlock R, Maguire AR, Parsons VL. Stack AG, et al. Among authors: morlock r. BMJ Open. 2019 Aug 28;9(8):e031550. doi: 10.1136/bmjopen-2019-031550. BMJ Open. 2019. PMID: 31462487 Free PMC article.

Cite

Share

8

Cite

Share

Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization.

Pillinger MH, Bangalore S, Klein AB, Baumgartner S, Morlock R. Pillinger MH, et al. Among authors: morlock r. J Manag Care Spec Pharm. 2017 Jun;23(6):677-683. doi: 10.18553/jmcp.2017.23.6.677. J Manag Care Spec Pharm. 2017. PMID: 28530520

Cite

Share

9

Cite

Share

Patient-Reported Spectacle Independence Questionnaire (PRSIQ): Development and Validation.

Morlock R, Wirth RJ, Tally SR, Garufis C, Heichel CWD. Morlock R, et al. Am J Ophthalmol. 2017 Jun;178:101-114. doi: 10.1016/j.ajo.2017.03.018. Epub 2017 Mar 22. Am J Ophthalmol. 2017. PMID: 28341605

Cite

Share

10

Cite

Share

The economic burden of uncontrolled gout: how controlling gout reduces cost.

Flores NM, Nuevo J, Klein AB, Baumgartner S, Morlock R. Flores NM, et al. Among authors: morlock r. J Med Econ. 2019 Jan;22(1):1-6. doi: 10.1080/13696998.2018.1532904. Epub 2018 Oct 24. J Med Econ. 2019. PMID: 30289009

Cite

Share